Plexus (PLXS) Projected to Post Quarterly Earnings on Wednesday

Key Points

• Plexus (PLXS) is set to announce its Q4 2025 earnings on October 22nd, with analysts predicting earnings of $1.84 per share and revenue of $1.046 billion.
• The company reported Q3 earnings of $1.90 per share, exceeding estimates, and noted a 6.0% year-over-year revenue increase.
• Insider selling has occurred, with CFO and CAO both reducing their holdings, and institutional investors owning 94.45% of the company's stock.

Plexus (NASDAQ:PLXS - Get Free Report) is expected to be announcing its Q4 2025 results before the market opens on Wednesday, October 22nd. Analysts expect the company to announce earnings of $1.84 per share and revenue of $1.0460 billion for the quarter. Plexus has set its Q4 2025 guidance at 1.820-1.970 EPS.Investors are encouraged to explore the company's upcoming Q4 2025 earningoverview page for the latest details on the call scheduled for Thursday, October 23, 2025 at 8:30 AM ET.

Plexus (NASDAQ:PLXS - Get Free Report) last posted its earnings results on Wednesday, July 23rd. The technology company reported $1.90 earnings per share for the quarter, beating the consensus estimate of $1.71 by $0.19. Plexus had a net margin of 4.04% and a return on equity of 12.33%. The business had revenue of $1.02 billion for the quarter, compared to analyst estimates of $1.02 billion. During the same quarter in the previous year, the business posted $1.45 EPS. The business's quarterly revenue was up 6.0% on a year-over-year basis. On average, analysts expect Plexus to post $6 EPS for the current fiscal year and $7 EPS for the next fiscal year.

Plexus Stock Performance

Shares of PLXS stock opened at $139.94 on Wednesday. Plexus has a 12 month low of $103.43 and a 12 month high of $172.89. The company has a debt-to-equity ratio of 0.06, a current ratio of 1.58 and a quick ratio of 0.74. The firm has a market capitalization of $3.78 billion, a P/E ratio of 23.84 and a beta of 0.80. The company's fifty day moving average price is $138.16 and its two-hundred day moving average price is $132.32.

Insider Buying and Selling

In other news, CFO Patrick John Jermain sold 2,500 shares of the business's stock in a transaction dated Wednesday, August 27th. The shares were sold at an average price of $137.71, for a total value of $344,275.00. Following the completion of the sale, the chief financial officer owned 20,959 shares of the company's stock, valued at approximately $2,886,263.89. The trade was a 10.66% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, CAO Angelo Michael Ninivaggi, Jr. sold 1,576 shares of the business's stock in a transaction dated Monday, August 25th. The stock was sold at an average price of $137.78, for a total transaction of $217,141.28. Following the completion of the sale, the chief accounting officer directly owned 24,495 shares of the company's stock, valued at $3,374,921.10. The trade was a 6.05% decrease in their position. The disclosure for this sale can be found here. In the last three months, insiders have sold 15,856 shares of company stock worth $2,142,440. 1.76% of the stock is currently owned by insiders.

Institutional Investors Weigh In On Plexus

A number of institutional investors have recently modified their holdings of PLXS. AQR Capital Management LLC grew its position in shares of Plexus by 103.1% during the 1st quarter. AQR Capital Management LLC now owns 8,384 shares of the technology company's stock valued at $1,074,000 after buying an additional 4,255 shares during the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. grew its position in shares of Plexus by 4.6% during the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 15,971 shares of the technology company's stock valued at $2,046,000 after buying an additional 705 shares during the last quarter. United Services Automobile Association bought a new stake in shares of Plexus during the 1st quarter valued at about $218,000. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC grew its position in shares of Plexus by 12.9% during the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 79,584 shares of the technology company's stock valued at $10,197,000 after buying an additional 9,078 shares during the last quarter. Finally, Cetera Investment Advisers bought a new stake in shares of Plexus during the 2nd quarter valued at about $309,000. Institutional investors own 94.45% of the company's stock.

Wall Street Analysts Forecast Growth

A number of equities analysts have commented on the stock. Wall Street Zen upgraded shares of Plexus from a "buy" rating to a "strong-buy" rating in a report on Saturday. Stifel Nicolaus set a $140.00 price objective on shares of Plexus in a report on Thursday, July 24th. Needham & Company LLC cut their price objective on shares of Plexus from $162.00 to $158.00 and set a "buy" rating on the stock in a report on Thursday, July 24th. Weiss Ratings reiterated a "hold (c+)" rating on shares of Plexus in a report on Wednesday, October 8th. Finally, Benchmark boosted their price objective on shares of Plexus from $160.00 to $165.00 and gave the stock a "buy" rating in a report on Monday, September 22nd. Three investment analysts have rated the stock with a Buy rating and three have given a Hold rating to the company. Based on data from MarketBeat.com, the company has a consensus rating of "Moderate Buy" and a consensus target price of $155.60.

About Plexus

Plexus Corp. provides electronic manufacturing services in the United States and internationally. It offers design, develop, supply chain, new product introduction, and manufacturing solutions, as well as sustaining services to companies in the healthcare/life sciences, industrial/commercial, aerospace/defense, and communications market sectors.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.